新華社通信, ワシントン, 12月 22 (タン・ジンジン記者) On the 22nd, アメリカ. Food and Drug Administration approved the first oral drug that can be used urgently to treat COVID-19 infections in adults and children aged 12 and older who have mild to moderate COVID-19 illnesses, as well as those at higher risk of severe illness. The US Drug …